Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
FLT3-ITD Mutated AML: PROs From the QuANTUM-First Trial of Quizartinib vs. Standard Chemo
By
Insights from 2023 ASH Annual Meeting
FEATURING
Esther Oliva
By
Insights from 2023 ASH Annual Meeting
FEATURING
Esther Oliva
Comments 0
Login to view comments.
Click here to Login
